José Luis Díaz-Díaz

Author

José Luis Díaz-Díaz

Hospital Universitario Virgen del Rocío ORCID

Also Known As

C del Peso, Francisco Arrieta, Iluminada García Polo, J L Delgado Prieto, J L Diaz Diaz, J L Diaz-Diaz, J. L. Diaz, J.L. Diaz, J.L. Diaz-Diaz, J.L. Díaz Díaz

145

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen del Rocío Hospital Clínico San Carlos Instituto Maimónides de Investigación Biomédica de Córdoba Hospital Universitario Reina Sofía Hospital Universitario Fundación Jiménez Díaz

About

José Luis Díaz-Díaz is an author at Hospital Universitario Virgen del Rocío specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.5K
2	Public Health	13	15	1.4K
3	Health Sciences	1	1	14
4	Social Sciences	1	1	57
5	Biochemistry	1	1	14

José Luis Díaz-Díaz

Publications

Citations

H-Index

Page 1

	Year	Citations
Lipoprotein(a) Levels in Familial Hypercholesterolemia Rodrigo Alonso, Eduardo Andrés‐León, Nelva Mata, Journal of the American College of Cardiology Metabolic SyndromeFamilial HypercholesterolemiaLipid DisorderCardiovascular DiseaseHyperlipidemia	2014	356
Predicting Cardiovascular Events in Familial Hypercholesterolemia Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, Circulation	2017	331
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons, The Lancet Family MedicineMetabolic SyndromeLipid DisorderCardiovascular DiseaseHealth Policy	2021	285
Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia Leopoldo Pérez de Isla, Rodrigo Alonso, Gerald F. Watts, Journal of the American College of Cardiology Family MedicineMetabolic SyndromeLipid DisorderCardiovascular DiseaseHealth Policy	2016	238
Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, Arteriosclerosis Thrombosis and Vascular Biology	2016	159
Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors Rodrigo Alonso, Nelva Mata, Sergio Castillo, Atherosclerosis Lipid DisorderEpidemiologyCardiovascular DiseaseFamilial HypercholesterolaemiaGlobal Health	2008	154
Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART) Nelva Mata, Rodrigo Alonso, Lina Badimón, Lipids in Health and Disease	2011	137
Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia Pablo Lázaro, Leopoldo Pérez de Isla, Gerald F. Watts, Journal of clinical lipidology Family MedicineFamilial HypercholesterolemiaGenetic TestingLipid DisorderHealth Policy	2017	113
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study Erik S.G. Stroes, John R. Guyton, Norman E. Lepor, Journal of the American Heart Association	2016	100
Home tracheotomy mechanical ventilation in patients with amyotrophic lateral sclerosis: causes, complications and 1-year survival Jesús Sancho, Emilio Servera, José Luis Díaz-Díaz, Thorax	2011	88

Page 1